C1orf198 promotes radioresistance in colorectal cancer by interacting with Septin2 and activating DNA damage repair
Frontiers in Pharmacology · 18.11.2026 · 17
DOI: 10.3389/fphar.2026.1885118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.11.2026. Verfasst von Hai Liang und 6 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Backround Radioresistance remains a major obstacle in colorectal cancer (CRC) treatment and is closely associated with enhanced DNA damage repair (DDR). This study investigated the role of C1orf198 in CRC progression and radioresistance, focusing on its interaction with Septin2.
Methods
C1orf198 expression was assessed using public databases, clinical CRC tissues, and cell lines. Functional effects were evaluated by CCK-8, colony formation, wound-healing, Transwell, flow cytometry, γ-H2AX immunofluorescence, comet assays, and xenograft experiments. Co-immunoprecipitation, cycloheximide chase, MG132 treatment, and ubiquitination assays were used to examine the C1orf198–Septin2 interaction and Septin2 stability. Septin2 overexpression was performed for rescue experiments.
Results
C1orf198 was upregulated in CRC tissues and cell lines, and high expression was associated with poor differentiation, advanced TNM stage, and unfavorable survival. C1orf198 knockdown suppressed CRC cell proliferation, migration, invasion, and xenograft growth. After irradiation, C1orf198 depletion reduced cell viability and clonogenic survival, increased G2/M arrest and apoptosis, and caused persistent DNA damage, as indicated by sustained γ-H2AX accumulation, increased comet-tail parameters, and reduced RAD51 expression. Mechanistically, C1orf198 interacted with Septin2 and enhanced its stability by inhibiting ubiquitin-mediated proteasomal degradation. Septin2 overexpression partially reversed the impaired cell survival and DNA repair, as well as the increased apoptosis, caused by C1orf198 knockdown.
Conclusion
C1orf198 promotes CRC progression and radioresistance by stabilizing Septin2 and supporting RAD51-associated DNA damage repair. The C1orf198–Septin2 axis may represent a potential target for radiosensitization in CRC.
Zitieren
APA
Liang, H., Zhao, H., Xia, R., Liu, J., Guo, Y., Yang, M., & Liu, Q. (2026). C1orf198 promotes radioresistance in colorectal cancer by interacting with Septin2 and activating DNA damage repair. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1885118
Vancouver
Liang H, Zhao H, Xia R, Liu J, Guo Y, Yang M, et al. C1orf198 promotes radioresistance in colorectal cancer by interacting with Septin2 and activating DNA damage repair. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1885118
BibTeX
@article{Liang2026,
author = {Liang, Hai and Zhao, Hanyu and Xia, Runan and Liu, Jiale and Guo, Yali and Yang, Miao and Liu, Qingchao},
title = {C1orf198 promotes radioresistance in colorectal cancer by interacting with Septin2 and activating DNA damage repair},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1885118}
}
EUVIMED